We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Higher Vitamin D Intake Needed to Reduce Cancer Risk

By LabMedica International staff writers
Posted on 09 Mar 2011
Print article
Researchers have reported that considerably higher intake of vitamin D is needed to reach blood levels that can prevent or significantly reduce the incidence of breast cancer and several other major diseases than had been previously believed.

The study's findings were published February 21, 2011, in the journal Anticancer Research. Investigators from the University of California, San Diego School of Medicine (UCSD; USA) and Creighton University School of Medicine (Omaha, NE, USA) conducted the research.

While these levels are higher than traditional intakes, they are largely in a range considered safe for daily use in a December 2010 report from the US National Academy of Sciences Institute of Medicine (Washington DC, USA;). "We found that daily intakes of vitamin D by adults in the range of 4,000 IU to 8,000 IU are needed to maintain blood levels of vitamin D metabolites in the range needed to reduce by about half the risk of several diseases--breast cancer, colon cancer, multiple sclerosis, and type 1 diabetes,” said Cedric Garland, DrPH, professor of family and preventive medicine at UC San Diego Moores Cancer Center. "I was surprised to find that the intakes required to maintain vitamin D status for disease prevention were so high--much higher than the minimal intake of vitamin D of 400 IU/day that was needed to defeat rickets in the 20th century.”

"I was not surprised by this,” said Robert P. Heaney, MD, of Creighton University, a biomedical scientist who has studied vitamin D need for several decades. "This result was what our dose-response studies predicted, but it took a study such as this, of people leading their everyday lives, to confirm it.”

The study reported on a survey of several thousand volunteers who were taking vitamin D supplements in the dosage range from 1,000 IU/day to 10,000 IU/day. Blood studies were conducted to determine the level of 25-vitamin D--the form in which nearly all vitamin D circulates in the blood.

"Most scientists who are actively working with vitamin D now believe that 40 ng/mL to 60 ng/mL is the appropriate target concentration of 25-vitamin D in the blood for preventing the major vitamin D-deficiency related diseases, and have joined in a letter on this topic,” said Garland. "Unfortunately, according a recent National Health and Nutrition Examination Survey, only 10% of the US population has levels in this range, mainly people who work outdoors.”

Interest in larger doses was spurred in December 2010, when a National Academy of Sciences Institute of Medicine committee identified 4,000 IU/day of vitamin D as safe for everyday use by adults and children nine years and older, with intakes in the range of 1,000 IU/day to 3,000 IU/day for infants and children through age eight years old.

While the IOM committee stated that 4,000 IU/day is a safe dosage, the recommended minimum daily intake is only 600 IU/day. "Now that the results of this study are in, it will become common for almost every adult to take 4,000 IU/day,” Dr. Garland said. "This is comfortably under the 10,000 IU/day that the IOM Committee Report considers as the lower limit of risk, and the benefits are substantial.” He added that individuals who may have contraindications should discuss their vitamin D needs with their family physician.

"Now is the time for virtually everyone to take more vitamin D to help prevent some major types of cancer, several other serious illnesses, and fractures,” concluded Dr. Heaney.

Related Links:

University of California, San Diego School of Medicine
Creighton University School of Medicine


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
ELISA System
ABSOL HS DUO
New
Serum Toxicology Benzodiazepine Assay
DRI Serum Toxicology Benzodiazepine Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.